{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:56:21Z","timestamp":1793890581874,"version":"4.8.0"},"reference-count":177,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T00:00:00Z","timestamp":1303430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Supportive care plays an increasingly important role in the modern management of multiple myeloma. While modern treatments have significantly prolonged overall and progression free survival through improved disease control, the vast majority of patients remain incurable, and live with the burden of the disease itself and the cumulative side effects of treatments. Maintenance of quality of life presents challenges at all stages of the disease from diagnosis through the multiple phases of active treatment to the end of life. Written on behalf of the British Committee for Standards in Haematology (BCSH) and the UK Myeloma Forum (UKMF), these evidence based guidelines summarize the current national consensus for supportive and symptomatic care in multiple myeloma in the following areas; pain management, peripheral neuropathy, skeletal complications, infection, anaemia, haemostasis and thrombosis, sedation, fatigue, nausea, vomiting, anorexia, constipation, diarrhoea, mucositis, bisphosphonate\u2010induced osteonecrosis of the jaw, complementary therapies, holistic needs assessment and end of life care. Although most aspects of supportive care can be supervised by haematology teams primarily responsible for patients with multiple myeloma, multidisciplinary collaboration involving specialists in palliative medicine, pain management, radiotherapy and surgical specialities is essential, and guidance is provided for appropriate interdisciplinary referral. These guidelines should be read in conjunction with the BCSH\/UKMF Guidelines for the Diagnosis and Management of Multiple Myeloma 2011.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2011.08574.x","type":"journal-article","created":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T05:39:48Z","timestamp":1303450788000},"page":"76-103","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["Guidelines for supportive care in multiple myeloma 2011"],"prefix":"10.1111","volume":"154","author":[{"given":"John A.","family":"Snowden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam H.","family":"Ahmedzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"D\u2019Sa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Littlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lucraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhona","family":"Maclean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Feyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the Haemato\u2010oncology Task Force of the British Committee for Standards in Haematology and UK Myeloma Forum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,22]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0521-2"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0b013e328151c401"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00082-1"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-149385"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.2086"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22921"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.9300"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra025411"},{"key":"e_1_2_14_10_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.12968\/denu.2006.33.5.270","article-title":"Bisphosphonate\u2010associated Osteonecrosis of the jaws: a guide for the general dental practitioner","volume":"33","author":"Barker K.","year":"2006","journal-title":"Dental Update"},{"key":"e_1_2_14_11_1","first-page":"718","article-title":"Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment","volume":"88","author":"Baron F.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903047880"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.4065\/80.12.1568"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00482-6"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.21.2558-c"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.10.034"},{"key":"e_1_2_14_17_1","first-page":"CD004310","article-title":"Megestrol acetate for the treatment of anorexia\u2010cachexia syndrome","volume":"18","author":"Berenstein E.G.","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1320"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200929060-00003"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07807.x"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08573.x"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2006.00739.x"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2008.0230"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02667.x"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60502-X"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.10.014"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2007.11.012"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-104984"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13782"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294983"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.141"},{"key":"e_1_2_14_32_1","first-page":"268","article-title":"Bisphosphonates and avascular necrosis of the jaws","volume":"48","author":"Carter G.D.","year":"2003","journal-title":"Australian Dental Journal"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11752"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.62.12.2291"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2007.00141.x"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh235"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90180-5"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.11.013"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079904X2114"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.04.022"},{"key":"e_1_2_14_41_1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood.V39.2.210.210","article-title":"Inhibition of fibrin monomer polymerization by lambda myeloma globulins","volume":"39","author":"Coleman M.","year":"1972","journal-title":"Blood"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002820-200310000-00012"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2008.06.014"},{"key":"e_1_2_14_44_1","unstructured":"Department of Health. (2008)End of life care strategy.http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_086277."},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112270"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970501)79:9<1717::AID-CNCR12>3.0.CO;2-0"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070594"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-004-0016-4"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-007-0006-1"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2008.n.017"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2005.11.003"},{"key":"e_1_2_14_52_1","doi-asserted-by":"publisher","DOI":"10.3171\/spi.2003.98.1.0021"},{"key":"e_1_2_14_53_1","first-page":"100","article-title":"Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study","volume":"30","author":"Gagnon B.","year":"2005","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.338S"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04970.x"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-7452-4"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04448.x"},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.07.013"},{"key":"e_1_2_14_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7390.635"},{"key":"e_1_2_14_60_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2009.0015"},{"key":"e_1_2_14_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20888"},{"key":"e_1_2_14_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05540.x"},{"key":"e_1_2_14_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/00130404-200203000-00013"},{"key":"e_1_2_14_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e3283311e13"},{"key":"e_1_2_14_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcm077"},{"key":"e_1_2_14_66_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0658"},{"key":"e_1_2_14_67_1","first-page":"2406","article-title":"Nausea and vomiting in people with cancer and other chronic diseases","author":"Keeley P.W.","year":"2009","journal-title":"Clinical Evidence (Online)"},{"key":"e_1_2_14_68_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.11.1480"},{"key":"e_1_2_14_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.11.013"},{"key":"e_1_2_14_70_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.0707onj"},{"key":"e_1_2_14_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq059"},{"key":"e_1_2_14_72_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.9591"},{"key":"e_1_2_14_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-151076"},{"key":"e_1_2_14_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(18)30205-6"},{"key":"e_1_2_14_75_1","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle R.A.","year":"1995","journal-title":"Seminars in Hematology"},{"key":"e_1_2_14_76_1","doi-asserted-by":"publisher","DOI":"10.4065\/78.1.21"},{"key":"e_1_2_14_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000131642.96984.74"},{"key":"e_1_2_14_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025313"},{"key":"e_1_2_14_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90308-I"},{"key":"e_1_2_14_80_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216309356138"},{"key":"e_1_2_14_81_1","unstructured":"Leukemia and Lymphoma Society. (2006)Integrative medicine and complementary and alternative therapies as part of blood cancer care.http:\/\/www.leukemia\u2010lymphoma.org\/attachments\/National\/br_1150734030.pdf."},{"key":"e_1_2_14_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1007"},{"key":"e_1_2_14_83_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.11.2865"},{"key":"e_1_2_14_84_1","first-page":"762","article-title":"Effect of curcumin on expression of survivin, Bcl\u20102 and Bax in human multiple myeloma cell line","volume":"15","author":"Liu B.","year":"2007","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"e_1_2_14_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.1126"},{"key":"e_1_2_14_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1032"},{"key":"e_1_2_14_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2004.1.439"},{"key":"e_1_2_14_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.01.010"},{"key":"e_1_2_14_89_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-169565"},{"key":"e_1_2_14_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc747"},{"key":"e_1_2_14_91_1","first-page":"1","article-title":"Opioid\u2010induced hyperalgesia","author":"Mao J.","year":"2008","journal-title":"Pain Clinical Updates"},{"key":"e_1_2_14_92_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-18-08312.2002"},{"key":"e_1_2_14_93_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089160409000106"},{"key":"e_1_2_14_94_1","article-title":"Bortezomib (velcade)\u2010melphalan\u2010prednisone (VMP) versus velcade\u2010 thalidomide\u2010prednisone (VTP) in elderly untreated multiple myeloma patients: which is the best partner for velcade: an alkylating or an immunomodulator agent?","volume":"112","author":"Mateos M.V.","year":"2008","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"e_1_2_14_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06946.x"},{"key":"e_1_2_14_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2006.10.061"},{"key":"e_1_2_14_97_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0918"},{"key":"e_1_2_14_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2004.07.010"},{"key":"e_1_2_14_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23336"},{"key":"e_1_2_14_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.05.6689"},{"key":"e_1_2_14_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800215)45:4<647::AID-CNCR2820450405>3.0.CO;2-E"},{"key":"e_1_2_14_102_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn250"},{"key":"e_1_2_14_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2005.07.002"},{"key":"e_1_2_14_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2004.12.005"},{"key":"e_1_2_14_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1710"},{"key":"e_1_2_14_106_1","first-page":"352","article-title":"The addition of thalidomide to the induction treatment of newly presenting myeloma patients increases the CR rate which is likely to translate into improved PFS and OS","volume":"114","author":"Morgan G.I.","year":"2009","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"e_1_2_14_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1090-3801(98)90020-9"},{"key":"e_1_2_14_108_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02183.x"},{"key":"e_1_2_14_109_1","first-page":"CD002920","article-title":"Nutrition support for bone marrow transplant patients","volume":"21","author":"Murray S.M.","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_14_110_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2273"},{"key":"e_1_2_14_111_1","unstructured":"NCCN. (2010)NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Cancer\u2010and\u2010Chemotherapy\u2010Induced Anemia. Version 2.2011.http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/anemia.pdf."},{"key":"e_1_2_14_112_1","unstructured":"NICE. (2003a)Improving outcomes in haematological cancers\u2010The Manual. National Institute for Health and Clinical Excellence.http:\/\/www.nice.org.uk\/docref.asp?d=90429."},{"key":"e_1_2_14_113_1","volume-title":"Interventional Procedure Guidance 20","author":"National Institute for Clinical Excellence (NICE)","year":"2003"},{"key":"e_1_2_14_114_1","unstructured":"NICE. (2004)Improving supportive and palliative care for adults with cancer \u2013 The Manual. National Institute for Clinical Excellencehttp:\/\/www.nice.org.uk\/nicemedia\/live\/10893\/28816\/28816.pdf."},{"key":"e_1_2_14_115_1","unstructured":"NIH Consensus Statement. (1997)Acupuncture. NIH Consensus Statement Online.http:\/\/consensus.nih.gov\/1997\/1997acupuncture107html.htm.15 1\u201334."},{"key":"e_1_2_14_116_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-005-0062-4"},{"key":"e_1_2_14_117_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1992.tb06033.x"},{"key":"e_1_2_14_118_1","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.4.650"},{"key":"e_1_2_14_119_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.08.131"},{"key":"e_1_2_14_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68338-4"},{"key":"e_1_2_14_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405062"},{"key":"e_1_2_14_122_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-117457"},{"key":"e_1_2_14_123_1","first-page":"652","article-title":"A prospective, randomized, phase III study of bortezomib, melphalan, prednisone and thalidomide (VMPT) versus bortezomib, melphalan and prednisone (VMP) in elderly newly diagnosed myeloma patients","volume":"112","author":"Palumbo A.","year":"2008","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"e_1_2_14_124_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703870"},{"key":"e_1_2_14_125_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.83"},{"key":"e_1_2_14_126_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp165"},{"key":"e_1_2_14_127_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2006.00684.x"},{"key":"e_1_2_14_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70284-0"},{"key":"e_1_2_14_129_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.993"},{"key":"e_1_2_14_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2010.00840.x"},{"key":"e_1_2_14_131_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2010.00841.x"},{"key":"e_1_2_14_132_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.8.837"},{"key":"e_1_2_14_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2006.01.004"},{"key":"e_1_2_14_134_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030288"},{"key":"e_1_2_14_135_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015909"},{"key":"e_1_2_14_136_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.7779"},{"key":"e_1_2_14_137_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.3087"},{"key":"e_1_2_14_138_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-300541"},{"key":"e_1_2_14_139_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1088"},{"key":"e_1_2_14_140_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021420"},{"key":"e_1_2_14_141_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196712212772503"},{"key":"e_1_2_14_142_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1983.tb02091.x"},{"key":"e_1_2_14_143_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830310111"},{"key":"e_1_2_14_144_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2009.01568.x"},{"key":"e_1_2_14_145_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-1-47"},{"key":"e_1_2_14_146_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007991003787318"},{"key":"e_1_2_14_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)00178-H"},{"key":"e_1_2_14_148_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi267"},{"key":"e_1_2_14_149_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-004-0595-4"},{"key":"e_1_2_14_150_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-022814"},{"key":"e_1_2_14_151_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-009-9512-0"},{"key":"e_1_2_14_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2008.02.009"},{"key":"e_1_2_14_153_1","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0b013e32830c9060"},{"key":"e_1_2_14_154_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.845"},{"key":"e_1_2_14_155_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1963.00460110102011"},{"key":"e_1_2_14_156_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi156"},{"key":"e_1_2_14_157_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20405"},{"key":"e_1_2_14_158_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-6-200709180-00010"},{"key":"e_1_2_14_159_1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/082585970902500304","article-title":"Transdermal fentanyl as a front\u2010line approach to moderate\u2010severe pain: a meta\u2010analysis of randomized clinical trials","volume":"25","author":"Tassinari D.","year":"2009","journal-title":"Journal of Palliative Care"},{"key":"e_1_2_14_160_1","unstructured":"Tavares M.(2003)National Guidelines for the use of complementary therapies in supportive palliative care.http:\/\/www.fih.org.uk\/information_library\/publications\/health_guidelines\/complementary.html."},{"key":"e_1_2_14_161_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707377"},{"key":"e_1_2_14_162_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21603"},{"key":"e_1_2_14_163_1","doi-asserted-by":"publisher","DOI":"10.1177\/1534735405279600"},{"key":"e_1_2_14_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-4296(03)00031-6"},{"key":"e_1_2_14_165_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2007.00325.x"},{"key":"e_1_2_14_166_1","volume-title":"Palliative Care Formulary","author":"Twycross R.","year":"2008"},{"key":"e_1_2_14_167_1","first-page":"1269","article-title":"Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation","volume":"90","author":"Vanstraelen G.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_14_168_1","first-page":"93","article-title":"WHO guidelines for the use of analgesics in cancer pain","volume":"7","author":"Ventafridda V.","year":"1985","journal-title":"International Journal of Tissue Reactions"},{"key":"e_1_2_14_169_1","doi-asserted-by":"publisher","DOI":"10.2174\/157015908783769644"},{"key":"e_1_2_14_170_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1971.00490050038003"},{"key":"e_1_2_14_171_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20382"},{"key":"e_1_2_14_172_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070596"},{"key":"e_1_2_14_173_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24279"},{"key":"e_1_2_14_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2006.12.005"},{"key":"e_1_2_14_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.04.018"},{"key":"e_1_2_14_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)04147-0"},{"key":"e_1_2_14_177_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05078.x"},{"key":"e_1_2_14_178_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0154"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2011.08574.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2011.08574.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:40:11Z","timestamp":1697380811000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2011.08574.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,22]]},"references-count":177,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1111\/j.1365-2141.2011.08574.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08574.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,22]]},"assertion":[{"value":"2011-04-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}